A comparative study of the efficacy and tolerability of maintenance treatment of patients with mild/moderate persistent asthma with Asmanex Twisthaler 220 mcg QD PM versus 'Asmanex' placebo QD PM.
Phase of Trial: Phase IV
Latest Information Update: 26 Jun 2014
At a glance
- Drugs Mometasone (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme; Schering-Plough
- 20 Apr 2010 Actual patient number (26) added as reported by ClinicalTrials.gov.
- 22 Aug 2007 Status changed from recruiting to discontinued.
- 10 Apr 2007 New trial record.